当前位置:主页 > 医学论文 > 肿瘤论文 >

热疗联合培美曲塞、顺铂治疗中晚期肺腺癌的疗效分析

发布时间:2018-06-26 10:24

  本文选题:热疗 + 培美曲塞 ; 参考:《中国药房》2017年33期


【摘要】:目的:观察热疗联合培美曲塞、顺铂治疗中晚期肺腺癌的疗效和安全性。方法:回顾性分析120例中晚期肺腺癌患者资料,按治疗方案不同分为对照组(60例)和观察组(60例)。对照组患者给予注射用培美曲塞二钠500 mg/m~2,静脉滴注,d1+注射用顺铂75 mg/m~2,静脉滴注,d2~4(分3 d使用)。21 d为1个周期,至少化疗2个周期。观察组患者在对照组化疗的基础上行热疗每月1次,共2~4次。观察两组患者的临床疗效,生活质量改善情况及毒副反应发生情况。结果:两组患者至少接受2个周期治疗。观察组患者总有效率(63.3%)显著高于对照组(36.7%),生活质量改善率(60.0%)显著高于对照组(33.3%),差异均有统计学意义(P0.05)。两组患者Ⅲ~Ⅳ度肝肾功能损害、骨髓抑制、消化道反应发生率比较,差异均无统计学意义(P0.05)。结论:热疗联合培美曲塞、顺铂治疗中晚期肺腺癌的疗效显著,可提高生存质量,且未增加严重毒副反应的发生率。
[Abstract]:Objective: to observe the efficacy and safety of hyperthermia combined with pemetrexide and cisplatin in the treatment of advanced lung adenocarcinoma. Methods: 120 patients with advanced lung adenocarcinoma were retrospectively analyzed and divided into control group (n = 60) and observation group (n = 60). Patients in the control group were given pemetrexed disodium 500 mg / mm-2, cisplatin 75 mg / m-2 for intravenously infused D1, and pemetrexide for 3 days for 21 days, at least 2 cycles of chemotherapy. The patients in the observation group were treated with hyperthermia once a month on the basis of chemotherapy in the control group. To observe the clinical effect, quality of life improvement and side effects of the two groups. Results: two groups of patients received at least 2 cycles of treatment. The total effective rate (63.3%) in the observation group was significantly higher than that in the control group (36.7%), and the improvement rate of quality of life (60.0%) was significantly higher than that in the control group (33.3%), the difference was statistically significant (P0.05). There was no significant difference in the incidence of liver and kidney dysfunction, bone marrow suppression and digestive tract reaction between the two groups (P0.05). Conclusion: hyperthermia combined with pemetrexide is effective in the treatment of middle and advanced lung adenocarcinoma. It can improve the quality of life and does not increase the incidence of severe side effects.
【作者单位】: 解放军第150中心医院肿瘤科;
【分类号】:R734.2

【相似文献】

相关期刊论文 前10条

1 赵莹莹;卢绍禹;杜文;梁洁;杨艳华;;变性高效液相色谱法检测晚期肺腺癌人类表皮生长因子受体2突变的探索性研究[J];中国医学创新;2013年07期

2 王中奇;邓海滨;张铭;周卫东;吴继;赵晓珍;王立芳;白冰;徐振晔;;中药分阶段结合化疗治疗晚期肺腺癌临床研究[J];上海中医药杂志;2010年03期

3 王立芳;徐振晔;金长娟;王中奇;邓海滨;张铭;周卫东;李敏;吴继;赵晓珍;白冰;吴秋霞;;中医药分阶段结合化疗治疗晚期肺腺癌临床研究[J];上海中医药杂志;2010年06期

4 李春娟;王俊峰;韩为清;许娜;;晚期肺腺癌的临床治疗与分析[J];医学信息(上旬刊);2011年01期

5 赵晓;燕翔;孙胜杰;吴志勇;焦顺昌;;晚期肺腺癌患者外周血T淋巴细胞亚群检测的临床意义[J];南方医科大学学报;2012年05期

6 燕翔;赵晓;焦顺昌;胡毅;孙胜杰;吴亮亮;吴志勇;;晚期肺腺癌患者外周血T细胞淋巴亚群的检测及危险因素评估[J];中国医学科学院学报;2012年03期

7 孙婧华;张阳;赵金波;刘芳;戴朝霞;蒋葵;冯仲珉;孙秀华;;埃克替尼治疗17例晚期肺腺癌非吸烟患者的早期临床疗效观察[J];中国新药杂志;2012年14期

8 王桂平;韦敏;廖洪映;周琼;王妍;林竹贞;张彦焘;;早期和晚期肺腺癌的差异基因和信号通路富集分析[J];中国肿瘤;2013年01期

9 王丽;史美祺;;贝伐单抗联合化疗一线治疗晚期肺腺癌的疗效及安全性[J];中国肿瘤临床与康复;2013年02期

10 张洁;鲁晓宁;班丽英;;盐酸埃克替尼治疗50例晚期肺腺癌的临床观察[J];中国新药杂志;2013年09期

相关会议论文 前10条

1 张贝贝;何春晓;宋正波;娄广媛;余新民;赵s,

本文编号:2070067


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/zlx/2070067.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户82117***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com